Phenyl Amino Pyrimidine Compounds and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/AU2008/000339, filed Mar 12, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,238,628 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| US 12,570,614 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| US 9,233,934 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| US 8,486,941 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| Application 14/960,710 | Phenyl Amino Pyrimidine Compounds and Uses Thereof Abandoned Abandoned Jun 13, 2022 | GlaxoSmithKline LLC | Abandoned | Abandoned Jun 13, 2022 | ||
| Application 19/459,164 | Phenyl Amino Pyrimidine Compounds and Uses Thereof Pending Not granted | GlaxoSmithKline LLC | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.